Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Clinical trial NCT06270082 · TERMINATED

Trial details

NCT number: NCT06270082
Sponsor: Ikena Oncology
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Colorectal Cancer Pancreatic Cancer Malignant Melanoma Ras (Kras or Nras) Gene Mutation BRAF Gene Mutation CRAF Gene Mutation Non-Small Cell Lung Carcinoma Thyroid Carcinoma Gliomas, Malignant

Start date: 2023-12-18
Primary completion: 2025-09-08
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.